focus -WSS

focus

author：entertainment 2025-10-02 12:32:26 - browse：4729

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： 2023 STAT Wunderkinds: get to know the winners

WSS

Celiac disease study examines precisely how gluten triggers injury

Can CDC director Mandy Cohen drive consensus in Washington?

Will Ozempic

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Congress: Eradicate hepatitis C and reduce the deficit

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

hotspot

focus

knowledge

Medical leaders decry Supreme Court decision on affirmative action

How climate

Heart attack and stroke risk calculators need revising

Everything to know for the next Powerball drawing as jackpot hits $1 billion

In age of alternative facts, a scholarly course on calling out crap

Solve the antibiotic resistance crisis with preventive drugs

United colonoscopy coverage change 'may cost lives,' doctors say

Lawmakers consider Medicare pay reforms for doctors

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pharmacists can make shortage drugs, but at what cost?

focus

How climate

Lawmakers consider Medicare pay reforms for doctors

STAT Readout Newsletter: Today's biggest biotech updates

Global childhood vaccinations edge closer to pre

Involuntary treatment for addiction doesn't work

Lawmakers consider Medicare pay reforms for doctors

hotspot

leisure time

hotspot

explore